ISARIC Outbreak Research Response Guidance

ISARIC has partnered with global experts to adapt its Clinical Epidemiology Platform, enabling research on the clinical characteristics of emerging infectious disease outbreaks to guide patient care and inform health policy. Dedicated to enhancing evidence generation, ISARIC provides tools and support for research teams to quickly set up studies address the research questions in their context and inform clinical trial design. The platform is also available for collaborative analyses that can characterise disease outbreaks across different variants, countries, and over time.

The ISARIC-WHO Clinical Characterisation Protocol and the ISARIC Clinical Epidemiology Platform is a suite of openly-available, standardised tools to support your research and facilitate global collaboration. Tools within this platform will help you to create a Case Report Form (CRF), launch a database, and perform statistical analysis on the data you collect.

Disease-specific outbreak response guidance are available at the following pages:

• ISARIC Mpox Research Response Guidance
• ISARIC Dengue Research Response Guidance
• ISARIC H5Nx Research Response Guidance